Provided is a sulfamide derivative having an adamantyl group represented by the following Formula 1, or a pharmaceutically acceptable salt thereof. The sulfamide derivative suppresses the activity of 11²-hydroxysteroid dehydrogenase type 1 (11²-HSD1), and is useful in the treatment of various diseases that are mediated by 11²-HSD1.